Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation

Background: The impact of ticagrelor-based dual antiplatelet therapy (DAPT) on acute coronary syndrome (ACS) in patients with chronic kidney disease (CKD) remains unclear. Methods: Data on a total of 1,067 ACS patients with CKD including end-stage renal disease (ESRD) who underwent new-generation dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Ji Woong, Lee, Seung-Jun, Kim, Byeong-Keuk, Hong, Sung-Jin, Kim, Hee-Yeol, Ahn, Chul-Min, Cho, Deok-Kyu, Kim, Jung-Sun, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785207/
https://www.ncbi.nlm.nih.gov/pubmed/35083294
http://dx.doi.org/10.3389/fcvm.2021.707722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785207/
https://www.ncbi.nlm.nih.gov/pubmed/35083294
http://dx.doi.org/10.3389/fcvm.2021.707722

Ejemplares similares